Fig. 7
MiR-101 inhibits the growth of LSCC in a xenograft tumour model. a The images of xenograft tumours in different treated groups. b Tumours in the miR-101-treated group had a smaller volume (cm3) than the tumours grown in the blank control group and the negative control group (PÂ <Â 0.05). c The average tumour weight (g) for the miR-101-treated group was also lower than that for the blank control group and the negative control group.